Response to Chen, “Endpoint applicability and post-response selection in digital care for acne-rosacea comorbidity”
Journal of the American Academy of Dermatology · 2026-11
DOI: 10.1016/j.jaad.2026.11.059 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-11. Verfasst von Yuanqin Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Department of Epidemiology and Biostatistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China; Department of Geriatric Endocrinology, Metabolism and Respiratory Medicine,Xi'an Jiao…
- Department of Dermatology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: jiawen702@126.comText.
Zitieren
APA
Wang, Y., Zhang, T., & Wu, J. (2026). Response to Chen, “Endpoint applicability and post-response selection in digital care for acne-rosacea comorbidity”. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.11.059
Vancouver
Wang Y, Zhang T, Wu J. Response to Chen, “Endpoint applicability and post-response selection in digital care for acne-rosacea comorbidity”. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.11.059
BibTeX
@article{Wang2026,
author = {Wang, Yuanqin and Zhang, Tianxiao and Wu, Jiawen},
title = {Response to Chen, “Endpoint applicability and post-response selection in digital care for acne-rosacea comorbidity”},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.11.059}
}
EUVIMED